The Korean journal of internal medicine

  • 제31권1호
  • /
  • Pages.98-105
  • /
  • 2016
  • /
  • 1226-3303(pISSN)
  • /
  • 2005-6648(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지
DOI QR코드

DOI QR Code

Relationship between metabolic syndrome and thyroid nodules in healthy Koreans

  • Shin, Juyoung (Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, The Catholic University of Korea) ;
  • Kim, Min-Hee (Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, The Catholic University of Korea) ;
  • Yoon, Kun-Ho (Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, The Catholic University of Korea) ;
  • Kang, Moo-Il (Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, The Catholic University of Korea) ;
  • Cha, Bong-Yun (Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, The Catholic University of Korea) ;
  • Lim, Dong-Jun (Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, The Catholic University of Korea)
  • 투고 : 2014.04.28
  • 심사 : 2015.05.13
  • 발행 : 2016.01.01
⟨ 이전 논문 다음 논문 ⟩

초록

Background/Aims: This study evaluated the relationship between thyroid nodules and metabolic syndrome (MS) and its components in apparently healthy Koreans. Methods: We reviewed the records of 3,298 subjects with no noticeable symptoms who underwent thyroid ultrasound imaging as part of a routine check-up between July 2009 and June 2010; of these, 1,308 were excluded based upon predefined criteria. Among the remaining 1,990 patients, we examined the association between MS and its components and the incidence of thyroid nodules. Results: Of the 1,990 subjects included in this study, 38.4% (n = 764) had thyroid nodules and 12.7% (n = 253) had MS. Female sex, older age, higher body mass index, larger waist circumference, higher glycated hemoglobin level, lower thyroid stimulating hormone level, and presence of MS were all closely related with the presence of thyroid nodules (all p < 0.05). Furthermore, the relevant number of MS components showed a positive linear correlation with the occurrence of thyroid nodules (p < 0.001). Evidence of MS alone was not independently associated with thyroid nodules after adjusting for sex and age in a multivariate binary logistic regression analysis; however, glycated hemoglobin for females and waist circumference for males, as well as both age and thyroid stimulating hormone for all patients, were identified as independent predictors for the existence of thyroid nodules (all p < 0.05). Conclusions: This study suggests a positive relationship between the components of MS and thyroid nodules in an ostensibly healthy Korean population. Our data support the idea that the recent increase in thyroid nodules is partly due to increases in both MS and obesity.

키워드

참고문헌

  1. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006;295:2164-2167. https://doi.org/10.1001/jama.295.18.2164
  2. Enewold L, Zhu K, Ron E, et al. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev 2009;18:784-791. https://doi.org/10.1158/1055-9965.EPI-08-0960
  3. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:1415-1428. https://doi.org/10.1016/S0140-6736(05)66378-7
  4. Lorenzo C, Williams K, Hunt KJ, Haffner SM. The National Cholesterol Education Program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 2007;30:8-13. https://doi.org/10.2337/dc06-1414
  5. Pothiwala P, Jain SK, Yaturu S. Metabolic syndrome and cancer. Metab Syndr Relat Disord 2009;7:279-288. https://doi.org/10.1089/met.2008.0065
  6. Esposito K, Chiodini P, Capuano A, et al. Metabolic syndrome and postmenopausal breast cancer: systematic review and meta-analysis. Menopause 2013;20:1301-1309. https://doi.org/10.1097/GME.0b013e31828ce95d
  7. Russo A, Autelitano M, Bisanti L. Metabolic syndrome and cancer risk. Eur J Cancer 2008;44:293-297. https://doi.org/10.1016/j.ejca.2007.11.005
  8. Lund Haheim L, Wisloff TF, Holme I, Nafstad P. Metabolic syndrome predicts prostate cancer in a cohort of middle-aged Norwegian men followed for 27 years. Am J Epidemiol 2006;164:769-774. https://doi.org/10.1093/aje/kwj284
  9. Ayturk S, Gursoy A, Kut A, Anil C, Nar A, Tutuncu NB. Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area. Eur J Endocrinol 2009;161:599-605. https://doi.org/10.1530/EJE-09-0410
  10. Rezzonico JN, Rezzonico M, Pusiol E, Pitoia F, Niepomniszcze H. Increased prevalence of insulin resistance in patients with differentiated thyroid carcinoma. Metab Syndr Relat Disord 2009;7:375-380. https://doi.org/10.1089/met.2008.0062
  11. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497. https://doi.org/10.1001/jama.285.19.2486
  12. Kim JY, Kim KR. Dietary iodine intake and urinary iodine excretion in patients with thyroid diseases. Yonsei Med J 2000;41:22-28. https://doi.org/10.3349/ymj.2000.41.1.22
  13. Saydah SH, Loria CM, Eberhardt MS, Brancati FL. Abnormal glucose tolerance and the risk of cancer death in the United States. Am J Epidemiol 2003;157:1092-1100. https://doi.org/10.1093/aje/kwg100
  14. Tulinius H, Sigfusson N, Sigvaldason H, Bjarnadottir K, Tryggvadottir L. Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders. Cancer Epidemiol Biomarkers Prev 1997;6:863-873.
  15. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004;4:579-591. https://doi.org/10.1038/nrc1408
  16. Ibrahim YH, Yee D. Insulin-like growth factor-I and cancer risk. Growth Horm IGF Res 2004;14:261-269. https://doi.org/10.1016/j.ghir.2004.01.005
  17. Iribarren C, Haselkorn T, Tekawa IS, Friedman GD. Cohort study of thyroid cancer in a San Francisco Bay area population. Int J Cancer 2001;93:745-750. https://doi.org/10.1002/ijc.1377
  18. Yin J, Wang C, Shao Q, et al. Relationship between the prevalence of thyroid nodules and metabolic syndrome in the iodine-adequate area of Hangzhou, China: a cross-sectional and cohort study. Int J Endocrinol 2014;2014:675796.
  19. Wang K, Yang Y, Wu Y, et al. The association between insulin resistance and vascularization of thyroid nodules. J Clin Endocrinol Metab 2015;100:184-192. https://doi.org/10.1210/jc.2014-2723
  20. Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med 1993;328:553-559. https://doi.org/10.1056/NEJM199302253280807
  21. Kim JY, Jung EJ, Park ST, et al. Body size and thyroid nodules in healthy Korean population. J Korean Surg Soc 2012;82:13-17. https://doi.org/10.4174/jkss.2012.82.1.13
  22. Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. BMC Public Health 2007;7:220. https://doi.org/10.1186/1471-2458-7-220
  23. Zhan YS, Feng L, Tang SH, et al. Glucose metabolism disorders in cancer patients in a Chinese population. Med Oncol 2010;27:177-184. https://doi.org/10.1007/s12032-009-9189-9
  24. Zivaljevic V, Vlajinac H, Jankovic R, Marinkovic J, Diklic A, Paunovic I. Case-control study of anaplastic thyroid cancer. Tumori 2004;90:9-12.
  25. Gerich JE. Clinical significance, pathogenesis, and management of postprandial hyperglycemia. Arch Intern Med 2003;163:1306-1316. https://doi.org/10.1001/archinte.163.11.1306
  26. Heine RJ, Balkau B, Ceriello A, Del Prato S, Horton ES, Taskinen MR. What does postprandial hyperglycaemia mean? Diabet Med 2004;21:208-213. https://doi.org/10.1111/j.1464-5491.2004.01149.x
  27. Ko SH, Kim SR, Kim DJ, et al. 2011 Clinical practice guidelines for type 2 diabetes in Korea. Diabetes Metab J 2011;35:431-436. https://doi.org/10.4093/dmj.2011.35.5.431
  28. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327-1334. https://doi.org/10.2337/dc09-9033
  29. Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D, Davidson MB. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab 2008;93:2447-2453. https://doi.org/10.1210/jc.2007-2174
  30. Bennett CM, Guo M, Dharmage SC. HbA(1c) as a screening tool for detection of type 2 diabetes: a systematic review. Diabet Med 2007;24:333-343. https://doi.org/10.1111/j.1464-5491.2007.02106.x
  31. Dal Maso L, La Vecchia C, Franceschi S, et al. A pooled analysis of thyroid cancer studies. V. Anthropometric factors. Cancer Causes Control 2000;11:137-144. https://doi.org/10.1023/A:1008938520101
  32. Engeland A, Tretli S, Akslen LA, Bjorge T. Body size and thyroid cancer in two million Norwegian men and women. Br J Cancer 2006;95:366-370. https://doi.org/10.1038/sj.bjc.6603249
  33. Kitahara CM, Platz EA, Park Y, Hollenbeck AR, Schatzkin A, Berrington de Gonzalez A. Body fat distribution, weight change during adulthood, and thyroid cancer risk in the NIH-AARP Diet and Health Study. Int J Cancer 2012;130:1411-1419. https://doi.org/10.1002/ijc.26161
  34. Elte JW, Bussemaker JK, Haak A. The natural history of euthyroid multinodular goitre. Postgrad Med J 1990;66:186-190. https://doi.org/10.1136/pgmj.66.773.186
  35. Oh JY, Sung YA, Lee HJ. Elevated thyroid stimulating hormone levels are associated with metabolic syndrome in euthyroid young women. Korean J Intern Med 2013;28:180-186. https://doi.org/10.3904/kjim.2013.28.2.180
  36. Lim S, Shin H, Song JH, et al. Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998-2007. Diabetes Care 2011;34:1323-1328. https://doi.org/10.2337/dc10-2109

피인용 문헌

  1. Does the Risk of Metabolic Syndrome Increase in Thyroid Cancer Survivors? vol.27, pp.7, 2016, https://doi.org/10.1089/thy.2016.0624
  2. Gender Disparity in the Relationship between Prevalence of Thyroid Nodules and Metabolic Syndrome Components: The SHDC-CDPC Community-Based Study vol.2017, pp.None, 2017, https://doi.org/10.1155/2017/8481049
  3. Associations of adiposity measurements with thyroid nodules in Chinese children living in iodine-sufficient areas: an observational study vol.7, pp.10, 2016, https://doi.org/10.1136/bmjopen-2017-016706
  4. Associations of adiposity measurements with thyroid nodules in Chinese children living in iodine-sufficient areas: an observational study vol.7, pp.10, 2016, https://doi.org/10.1136/bmjopen-2017-016706
  5. The Association of Thyroid Nodules with Metabolic Status: A Cross-Sectional SPECT-China Study vol.2018, pp.None, 2016, https://doi.org/10.1155/2018/6853617
  6. The Impact of Metabolic Syndrome on Increased Risk of Thyroid Nodules and Size vol.5, pp.None, 2016, https://doi.org/10.1177/2333392818775517
  7. Prevalence and Annual Incidence of Thyroid Disease in Korea from 2006 to 2015: A Nationwide Population-Based Cohort Study vol.33, pp.2, 2016, https://doi.org/10.3803/enm.2018.33.2.260
  8. Association of thyroid nodules with adiposity: a community-based cross-sectional study in China vol.18, pp.1, 2016, https://doi.org/10.1186/s12902-018-0232-8
  9. Relationship Between the Neutrophil to Lymphocyte Ratio and the Presence and Size of Thyroid Nodules vol.11, pp.1, 2019, https://doi.org/10.7759/cureus.3866
  10. Relationship between metabolic syndrome and thyroid nodules and thyroid volume in an adult population vol.65, pp.2, 2016, https://doi.org/10.1007/s12020-019-01901-4
  11. The Effect of Inflammation on the Formation of Thyroid Nodules vol.2020, pp.None, 2016, https://doi.org/10.1155/2020/9827349
  12. Association of Changes in Metabolic Syndrome Status With the Incidence of Thyroid Nodules: A Prospective Study in Chinese Adults vol.11, pp.None, 2016, https://doi.org/10.3389/fendo.2020.00582
  13. An analysis of the correlation between thyroid nodules and metabolic syndrome vol.9, pp.9, 2016, https://doi.org/10.1530/ec-20-0398
  14. The Association Between Hyperhomocysteinemia and Thyroid Nodule Prevalence in an Adult Population vol.18, pp.8, 2016, https://doi.org/10.1089/met.2020.0057
  15. Metabolic Syndrome and the Risk of Thyroid Cancer: A Nationwide Population-Based Cohort Study vol.30, pp.10, 2016, https://doi.org/10.1089/thy.2019.0699
  16. Prevalence of Thyroid Nodules in China: A Health Examination Cohort-Based Study vol.12, pp.None, 2016, https://doi.org/10.3389/fendo.2021.676144
  17. Six Air Pollutants Associated With Increased Risk of Thyroid Nodules: A Study of 4.9 Million Chinese Adults vol.12, pp.None, 2016, https://doi.org/10.3389/fendo.2021.753607
  18. Can “VAI” Better Indicate Metabolic Syndrome Compared with Other Metabolic Syndrome-Related Parameters in Patients with Thyroid Nodules? A Study from Turkey vol.19, pp.6, 2016, https://doi.org/10.1089/met.2020.0147
  19. Geographical influences on thyroid abnormalities in adult population from iodine-replete regions: a cross-sectional study vol.11, pp.1, 2016, https://doi.org/10.1038/s41598-020-80248-7
  20. Prevalence and associated metabolic factors for thyroid nodules: a cross-sectional study in Southwest of China with more than 120 thousand populations vol.21, pp.1, 2021, https://doi.org/10.1186/s12902-021-00842-2